(lp0
S"BTIG Downgrades AtriCure Inc.  to Neutral StreetInsider.com - Mar 6, 2017 BTIG downgraded AtriCure Inc.  from Buy to Neutral. Analyst Dr. Sea Lavin comments &quot;We followed up with ATRC's management team following the company's earnings report at our Snowbird conference.AtriCure Inc.  Plunges 6.01% on March 06 - Equities.comAtriCure Announces hiring of Senior Vice President of Clinical, Regulatory ... - Yahoo Finance"
p1
aS'AtriCure - Management Needs To Find A Cure For Continued Losses Seeking Alpha - Jan 18, 2017 AtriCure is a great growth story but losses, and the resultant dilution, limit growth for investors. Despite solid growth prospects going forwards, investors are anticipating further dilution as well as profits are not yet in sight.'
p2
aS'AtriCure Names National Principal Investigator for the CONVERGE IDE Clinical Trial Business Wire  - Mar 14, 2017 MASON, Ohio----AtriCure, Inc. , a leading innovator in surgical treatments for atrial fibrillation  and left atrial appendage management, today announced that it has named Dr.'
p3
aS"The AtriCure Inc.  Shares Sold by Fmr LLC Petro Global News 24 - 21 hours ago Fmr LLC cut its stake in AtriCure Inc.  by 3.2% during the fourth quarter, Holdings Channel reports. The institutional investor owned 4,820,000 shares of the medical device company's stock after selling 160,438 shares during the period.AtriCure, Inc.  Reviewed By Analysts - The De Soto Edge"
p4
aS'Stock Returns: AtriCure Inc  versus CryoLife Inc  CML News - Mar 14, 2017 This is a snapshot to compare the stock returns for AtriCure Inc  versus CryoLife Inc  . The stock return points we compare look at the last three-months, six-months and twelve-months.'
p5
aS'AtriCure Inc.: AtriCure Reports Fourth Quarter and Full Year 2016 Financial ... The Wall Street Transcript - Mar 2, 2017 MASON, Ohio----Feb. 28, 2017-- AtriCure, Inc. , a leading innovator in treatments for atrial fibrillation  and left atrial appendage  management, today announced fourth quarter and full year 2016 financial results.'
p6
aS'AtriCure Enters Into Definitive Agreement to Acquire nContact Business Wire  - Oct 4, 2015 WEST CHESTER, Ohio----AtriCure, Inc. , a leading innovator in treatments for atrial fibrillation  and left atrial appendage management, today announced that it has entered into a definitive merger agreement under&nbsp;...Stock slips as AtriCure acquires competitor for $149M - Cincinnati Business CourierAtriCure to Buy Heart Device Developer nContact for $99M - Xconomy'
p7
aS'AtriCure Enrolls First Patient in Randomized Multi-Center Trial Evaluating ... Business Wire  - Feb 17, 2016 WEST CHESTER, Ohio----AtriCure, Inc. , a leading innovator in treatments for atrial fibrillation  and left atrial appendage management, announced today that the first patient was enrolled and treated at PinnacleHealth&nbsp;...'
p8
aS'AtriCure Inc.  Stake Reduced by Allianz Asset Management AG BNB Daily  - Mar 12, 2017 AtriCure logo Allianz Asset Management AG lowered its position in AtriCure Inc.  by 13.9% during the fourth quarter, Holdings Channel reports.The BTIG Research Lowers AtriCure Inc.  to Neutral - Petro Global News 24AtriCure Inc. - Receive News &amp; Ratings Daily - BBNS'
p9
aS"BRIEF-Hudson Executive Capital reports 5.6 pct stake in AtriCure Reuters - Jan 24, 2017 Reuters is the news and media division of Thomson Reuters. Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news&nbsp;..."
p10
a.